L Wang

Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia

L Wang, Athina Giannoudis, Steven Lane et al. · Clinical Pharmacology & Therapeutics · 2007 · 277 citations

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study

José M. Rojas, Katy Knight, L Wang et al. · Leukemia · 2007 · 108 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Bcr-abl Peptide Immunisation +10

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

Helen White, Liesbet Deprez, Philippe Corbisier et al. · Leukemia · 2014 · 81 citations · Full text

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

Jacqueline Boultwood, Janet Perry, R. Zaman et al. · Leukemia · 2010 · 79 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Engineering +11

Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages.

L Wang, M J Groves, M Hepburn et al. · PubMed · 2000 · 56 citations